Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Clinical Benefit of Ropeginterferon Alfa 2b (P1101) in Patients with Myelofibrosis

Jeanne Palmer, MD, Heidi E. Kosiorek, MS, Craig Zimmerman, PhD, Oleh Zagrijtschuk, MD, John Camoriano, MD, Ruben A. Mesa, MD

Blood (2018) 132 (Supplement 1): 5475.

https://doi.org/10.1182/blood-2018-99-115521

Published: 2018

Journal Articles

Prospective, Multi-Center, Phase I Clinical Trial of PLX-R18 Placental Expanded Adherent Stromal Cells in Subjects with Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation

Hillard M Lazarus, MD, Leland Metheny, MD, Tsila Zuckerman, MD, Carolina Escobar, MD, Joseph P. McGuirk, DO, Yael Rosen, MD, Jacob M. Rowe, MD

Blood (2018) 132 (Supplement 1): 3379.

https://doi.org/10.1182/blood-2018-99-116239

Published: 2018

Journal Articles

Oxidative Stress Levels Are Correlated with Disease Progression and Iron Overload in MDS Patients with Excess Blasts

Naomi Shimizu, MD PhD, Yasuhiro Watanabe, MD, Noriko Ban, MD PhD, Takashi Yamaguchi, MD PhD, Hidekazu Hasunuma, Youichi Iwashita, Hiromitsu Yokota, Chiaki Nakaseko, MD PhD, Hideaki Bujo, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2016) 128 (22): 5532.

https://doi.org/10.1182/blood.V128.22.5532.5532

Published: 2016

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, Edouard Forcade, MD, Kathy S. Wang, PhD, Eduardo L Espada, MD, Jennifer Whangbo, MD PhD, Carol G Reynolds, PhD, Marie J Chammas, Kazuyuki Murase, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 3425.

https://doi.org/10.1182/blood.V126.23.3425.3425

Published: 2015

Journal Articles

Lenalidomide As a Second-Line Therapy after Failure of Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Hawk Kim, MD PhD, Je-Hwan Lee, MD PhD, Won-Sik Lee, MD, Inho Kim, Joon Ho Moon, MD, PhD, Chul Won Choi, MD PhD, Ho Sup Lee, MD PhD, Jinny Park, Ho-Jin Shin, Kyoung Ha Kim, MD, Su-Hee Cho, MD PhD, Sung-Yong Kim, MD, Yoo-Jin Kim

Blood (2015) 126 (23): 1687.

https://doi.org/10.1182/blood.V126.23.1687.1687

Published: 2015

Journal Articles

Adiposity As a Principal Component of Lethal Cytokine Storm Following Cancer Immunotherapy in Aged Mice

Annie Mirsoian, Myriam N. Bouchlaka, BS, PhD, Gail Sckisel, PhD, Mingyi Chen, MD PhD, Chien-Chun Steven Pai, Emanuel Maverakis, MD, Richard Spencer, MD PhD FACP, Kenneth Fishbein, PhD, Sana Siddiqui, PhD, Arta Monjazeb, MDPhD, Bronwen Martin, PhD, Stuart Maudsley, PhD, Charles Hesdorffer, Luigi Ferrucci, MD PhD, Dan L. Longo, MD, Bruce R. Blazar, MD, Robert Wiltrout, PhD, Dennis D Taub, PhD, William J Murphy, PhD

Blood (2014) 124 (21): 460.

https://doi.org/10.1182/blood.V124.21.460.460

Published: 2014

Journal Articles

Host Immune Status Determines the Effects of Therapeutic Interleukin-2 Administration: Enhancement of GVL or Induction of Tolerance?

Yusuke Meguri, Takeru Asano, MD, Takanori Yoshioka, MD, Haruka Izumi, Yuriko Kishi, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD, Ken-ichi Matsuoka, MD PhD

Blood (2014) 124 (21): 2431.

https://doi.org/10.1182/blood.V124.21.2431.2431

Published: 2014

Journal Articles

New Interleukin-15 Superagonist (IL-15 SA) Combined with Donor Lymphocyte Infusion (DLI) Significantly Enhances Graft-Versus-Tumor Activity after Allogeneic Hematopoietic Stem Cell Transplantation

Cavan Bailey, BA, Michelle M Panis, BS, Cihangir Buyukgoz, MD, Tulin Budak-Alpdogan, MD, Neal Flomenberg, MD, Onder Alpdogan, MD

Blood (2014) 124 (21): 1118.

https://doi.org/10.1182/blood.V124.21.1118.1118

Published: 2014

Journal Articles

Probing the Impact of AMD3100/GCSF Mobilization on the Peripheral Blood T Cell Content Using a Rhesus Macaque Model: Increased Proportions of FoxP3+/CD4+ T Cells Occur After Mobilization and Leukapheresis

Leslie Kean, MD, PhD, Sharon Sen, Mark E Metzger, Aylin Bonifacino, Karnail Singh, Robert E Donahue, VMD

Blood (2010) 116 (21): 350.

https://doi.org/10.1182/blood.V116.21.350.350

Published: 2010

Journal Articles

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Stem Cell Transplant Recipients: Response to Immune Enhancement in Early Versus Late Serious Post-Transplant Infections

Amar Safdar, MD, Georgina Georgescu, MD, Gilhen Rodriguez, MD, Richard Champlin, MD

Blood (2008) 112 (11): 4373.

https://doi.org/10.1182/blood.V112.11.4373.4373

Published: 2008

Journal Articles

Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor Is an Alternative to Donor Lymphocyte Infusion for Relapse after Allogeneic Stem Cell Transplantation and Is Associated with Increase Immune Effector Cells and Polarization to Type 2 Dendritic Cells.

Carlos R. Bachier, MD, Paul Shaughnessy, MD, Brad Smith2, PhD, Richard Salinas, Charles F. LeMaistre, MD

Blood (2007) 110 (11): 1647.

https://doi.org/10.1182/blood.V110.11.1647.1647

Published: 2007

Journal Articles

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia.

Satoshi Hashino, MD, PhD, Fumie Fujisawa, MD, Takeshi Kondo, MD, PhD, Masahiro Imamura, MD, PhD, Kazuya Sato, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD, Keisuke Kimura, MD, PhD, Hiroyuki Furukawa, MD, PhD, Satoru Todo, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 5357.

https://doi.org/10.1182/blood.V108.11.5357.5357

Published: 2006

Journal Articles

Long Term Clinical Benefit of Lenalidomide (Revlimid) Treatment in Patients with Myelodysplastic Syndrome without Del 5q Cytogenetic Abnormalities.

Azra Raza, MD, James E. Reeves, MD, Eric J. Feldman, MD, H. Joachim Deeg, MD, Luke Dreisbach, MD, Charles A. Schiffer, MD, Jamile M. Shammo, MD, Virginia M. Klimek, MD, Peter L. Greenberg, MD, John M. Bennett, MD, Gordon W. DeWald, PhD, Jerome B. Zeldis, MD, PhD, Kenton Wride, MS, Michele Schmidt, RN,C, Robert D. Knight, MD, Alan F. List, MD

Blood (2006) 108 (11): 250.

https://doi.org/10.1182/blood.V108.11.250.250

Published: 2006

Journal Articles

Long-Term Clinical Benefit of Lenalidomide (Revlimid) Treatment in Patients with Myelodysplastic Syndrome and Chromosome Deletion 5q.

Alan F. List, MD, Gordon W. Dewald, PhD, John M. Bennett, MD, Aristoteles Giagounidis, MD, Azra Raza, MD, Eric J. Feldman, MD, Bayard L. Powell, MD, Peter L. Greenberg, MD, Stephen D. Nimer, MD, Jerome B. Zeldis, MD, PhD, Kenton Wride, MS, Michele Schmidt, RNC, Robert D. Knight, MD

Blood (2006) 108 (11): 251.

https://doi.org/10.1182/blood.V108.11.251.251

Published: 2006

Journal Articles

Cytokine or Cytokine Receptor Treatment Using Hematopoietic Secretory Lysosomes as Vehicles.

Markus Hansson, Jero Calafat, Ying Gao, Ann-Maj Persson, Hans Tapper, Inge Olsson

Blood (2004) 104 (11): 3814.

https://doi.org/10.1182/blood.V104.11.3814.3814

Published: 2004

Journal Articles

Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates

Ken Kuramoto, Dean A. Follmann, Peiman Hematti, Stephanie Sellers, Brian A. Agricola, Mark E. Metzger, Robert E. Donahue, Christof von Kalle, Cynthia E. Dunbar

Blood (2004) 103 (11): 4070–4077.

https://doi.org/10.1182/blood-2003-08-2934

Published: 2004

NARROW

Clinical Benefit of Ropeginterferon Alfa 2b (P1101) in Patients with Myelofibrosis

Prospective, Multi-Center, Phase I Clinical Trial of PLX-R18 Placental Expanded Adherent Stromal Cells in Subjects with Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation

Oxidative Stress Levels Are Correlated with Disease Progression and Iron Overload in MDS Patients with Excess Blasts

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Lenalidomide As a Second-Line Therapy after Failure of Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Adiposity As a Principal Component of Lethal Cytokine Storm Following Cancer Immunotherapy in Aged Mice

Host Immune Status Determines the Effects of Therapeutic Interleukin-2 Administration: Enhancement of GVL or Induction of Tolerance?

New Interleukin-15 Superagonist (IL-15 SA) Combined with Donor Lymphocyte Infusion (DLI) Significantly Enhances Graft-Versus-Tumor Activity after Allogeneic Hematopoietic Stem Cell Transplantation

Probing the Impact of AMD3100/GCSF Mobilization on the Peripheral Blood T Cell Content Using a Rhesus Macaque Model: Increased Proportions of FoxP3+/CD4+ T Cells Occur After Mobilization and Leukapheresis

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Stem Cell Transplant Recipients: Response to Immune Enhancement in Early Versus Late Serious Post-Transplant Infections

Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor Is an Alternative to Donor Lymphocyte Infusion for Relapse after Allogeneic Stem Cell Transplantation and Is Associated with Increase Immune Effector Cells and Polarization to Type 2 Dendritic Cells.

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia.

Long Term Clinical Benefit of Lenalidomide (Revlimid) Treatment in Patients with Myelodysplastic Syndrome without Del 5q Cytogenetic Abnormalities.

Long-Term Clinical Benefit of Lenalidomide (Revlimid) Treatment in Patients with Myelodysplastic Syndrome and Chromosome Deletion 5q.

Cytokine or Cytokine Receptor Treatment Using Hematopoietic Secretory Lysosomes as Vehicles.

Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only